CRL

Charles Riv Labs Intl Inc

173.89

-1.01-0.58%

After Hours: 173.89 0.00 0.00%19:35 04/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE170.53/174.90

TODAY RANGE170.52-179.83

VOL839.21K

MARKET CAP8.58B

52 WEEK RANGE91.86-228.88

AVG VOL (3M)989.20K

% TURNOVER1.70%

TURNOVER--

P/E (TTM)-59.7109

% RANGE5.11%

EPS(TTM)-2.9122

P/E(FORWARD)22.32

P/B2.704

BVPS64.30

DIVIDEND--

P/S2.131

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP8.46B

SHARES OUTSTANDING49.34M

NEXT EARNINGS05/05-05/11

FREE FLOAT48.66M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Seeking Alpha·32m ago
Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus
Dow Jones·4d ago
Charles River Laboratories International Inc. Stock Advances 8.0%, Outperforms Peers
MarketWatch·4d ago
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
Seeking Alpha·03/29 13:05
Notable healthcare headlines for the week: Merck, Medtronic, and Novartis in focus
Dow Jones·03/25 20:34
Charles River Laboratories International Inc. Stock Advances 4.2%, Outperforms Market
MarketWatch·03/25 20:30
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
Simply Wall St·03/23 17:10
Could Charles River (CRL) Using Locus Cell Tie-Up to Reframe Its Asia-Pacific Growth Strategy?
Seeking Alpha·03/18 16:38
FDA issues guidance on alternatives to animal testing
NASDAQ·03/16 20:56
Charles River Laboratories International is Now Oversold (CRL)
Seeking Alpha·03/15 13:05
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and CVS Health in focus
Simply Wall St·03/14 21:25
A Look At Charles River Laboratories (CRL) Valuation After Its Earnings Beat And New US$1b Buyback
Simply Wall St·03/13 13:20
Are Charles River’s New Advanced Therapy Deals Quietly Rewriting Its Drug-Development Moat Story (CRL)?
Dow Jones·03/12 20:33
Charles River Laboratories International Inc. Stock Slides 9.6%, Underperforms Peers
MarketWatch·03/12 20:30
Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors
Dow Jones·03/10 20:34
Charles River Laboratories International Inc. Stock Sheds 5.4%, Underperforms Peers

Same Industry

Name/Symbol

Change%

Price

CRL

Regeneron Pharmaceuticals

REGN

-1.98%

761.85

GRDX

BIONTECH

BNTX

+1.97%

91.18

UTHR

VRTX

SIGA

Moderna

MRNA

-1.66%

49.20

Medpace Holdings

MEDP

+1.81%

498.34

Talphera Inc

TLPH

-7.12%

0.7223

China Biologic

CBPO

0.00%

119.99

ICON PLC

ICLR

+2.49%

114.19

IQV

MOLN

Arcturus Therape

ARCT

+2.29%

8.03

PRAH

GILD

INCY

APVO

Biospecifics

BSTC

+0.15%

88.53

KNSA

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.